Verato Enrich is powered by the company's cloud-based enterprise master person index. It can append a wide array of data ranging from basic contact information like missing phone numbers and addresses, to lifestyle data like income, ethnicity, race, occupation, and interests to patient records.
Approximately 80% of positive COVID-19 test results are submitted electronically and current reports show that as many as 50% lack enough contact data to support contact tracing.
With Verato Enrich, health systems, commercial labs, and public health teams gain an increased understanding of people and the critical non-clinical factors that impact health.
Enrich acts as an accelerator, enabling contact tracing and analysis to be more efficient and effective. Shortening the cycle between infection notification and actionable data is the only way to ensure a rapid response and contain the virus.
Verato Enrich extends the value proposition of Verato's next-generation EMPI, providing a critical infrastructure backbone for contact tracing and public health analytics, enabling health organisations to accurately integrate information from a range of sources and efficiently drive actionable workflows and information sharing.
Verato is the next generation of EMPI and patient matching.
As a HITRUST-certified EMPI, over 50 of the nation's most innovative healthcare organizations rely on Verato Referential Matching to manage and link person data quickly and at scale.
Xbrane Biopharma renegotiates IP agreement with Vaxiion Therapeutics
Johnson & Johnson declares dividend of USD1.01 per share for Q1 2021
Pfizer's board approves higher dividend for Q1 2021
Medifast announces quarterly cash dividend
Medivir and TetraLogic renegotiate birinapant agreement
China Accepts Emapalumab Marketing Authorization Application for Review